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LETTER TO THE EDITOR
Sir,
We thank Dr Testino for his insightful commen-
tary on our recent review of steatohepatitis. The
consequence of hepatic steatosis in post-liver
transplant patients receiving antiviral treatment
for chronic hepatitis C is an interesting and im-
portant corollary to our paper. The relationship
between steatosis and hepatitis C is not well 
understood. However, studies have shown some
interesting associations. It is well known that
non-alcoholic fatty liver disease and steatosis 
are accelerants of hepatitis C progression1 and
the absence of steatosis is one of the important
treatment predictors for achieving sustained vi-
ralogic response in the management of patients
with HCV infection.2 Additionally, while hepatic
steatosis is a common general histologic feature
of HCV infection, HCV patients with genotype 
3 virus are more likely to have moderate to severe
steatosis. The mechanism by which this occurs
remains to be determined.3 With this knowledge,
it is important to address steatosis in all HCV 
patients, including the post-liver transplant 
population.
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